Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
BMJ 297: 883, 1988 90 Spencer K, Wallace EM, Ritoe S: Second-trimester dimeric inhibin-A in Down's syndrome screening
The SURMOUNT-1 trial showed average weight loss of 20.9% at the 15 mg dose, with 57% of participants losing more than 20% of body weight
Furthermore, murine models were presented with another dopamine agonist, haloperidol, and then presented with amphetamine on days 1, 2, 4, and 10
Rheumatology (Oxford) 64, 3085-3089 (2025)
US$ 22.25
US$ 26.46
US$ 23.43
US$ 23.88
